Guangzhou Kingmed Diagnostics Group Co (SHSE:603882) Short Interest

View and export this data going back to 2017. Start your Free Trial

What is Guangzhou Kingmed Diagnostics Group Co Short Interest?

Short Interest can be expressed as a percentage by dividing the number of shares sold short by the total number of outstanding shares.

Due to the license agreement change with our data vendor, Short Interest related data is no longer available on GuruFocus website.

Competitive Comparison of Guangzhou Kingmed Diagnostics Group Co's Short Interest

For the Diagnostics & Research subindustry, Guangzhou Kingmed Diagnostics Group Co's Short Interest, along with its competitors' market caps and Short Interest data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Guangzhou Kingmed Diagnostics Group Co's Short Interest Distribution in the Medical Diagnostics & Research Industry

For the Medical Diagnostics & Research industry and Healthcare sector, Guangzhou Kingmed Diagnostics Group Co's Short Interest distribution charts can be found below:

* The bar in red indicates where Guangzhou Kingmed Diagnostics Group Co's Short Interest falls into.

Save Embed

;

Save Embed

;

Guangzhou Kingmed Diagnostics Group Co Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Guangzhou Kingmed Diagnostics Group Co Ltd (SHSE:603882) » Definitions » Short Interest

Comparable Companies

Traded in Other Exchanges

N/A

Address

International Biological Island spiral three on the 10th, Guangdong Province, Guangzhou, CHN, 510000

Website

http://www.kingmed.com.cn

Founded in 1994, KingMed is the largest independent clinical laboratory in China. It was listed on the Shanghai Stock Exchange in 2017. As of 2023, KingMed has 49 centralized labs and provides over 4000 test items. Over 90% of its total revenue comes from clinical diagnostics. Furthermore, KingMed has been actively investing in its cold chain logistics. Its service network covers the most intensely populated areas in China.

Executives

Hao Bi Xi	Directors, senior managers
Wang Ling Lai	Director
Yu Shi Hui	senior management
Liang Yao Ming	Director
Peng Yong Xiang	Director

Guangzhou Kingmed Diagnostics Group Co Headlines

No Headlines